Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2004 1
2005 1
2006 1
2009 1
2010 1
2012 2
2013 1
2014 2
2015 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the roles of PALB2 at the crossroads of DNA repair and cancer.
Pauty J, Rodrigue A, Couturier A, Buisson R, Masson JY. Pauty J, et al. Biochem J. 2014 Jun 15;460(3):331-42. doi: 10.1042/BJ20140208. Biochem J. 2014. PMID: 24870022 Review.
PALB2 [partner and localizer of BRCA2 (breast cancer early-onset 2)] [corrected] has emerged as a key player in the maintenance of genome integrity. ...
PALB2 [partner and localizer of BRCA2 (breast cancer early-onset 2)] [corrected] has emerged as a key player in …
Familial breast cancer.
Steel CM, Cohen BB, Porter DE. Steel CM, et al. Semin Cancer Biol. 1992 Jun;3(3):141-50. Semin Cancer Biol. 1992. PMID: 1511156 Review.
Cytogenetic and 'Loss of Heterozygosity' (LOH) studies in sporadic breast cancers have pointed to several candidate loci for breast cancer genes but there is no clear consensus from these two approaches that might direct attention to any prime target region. Recent reports of tig …
Cytogenetic and 'Loss of Heterozygosity' (LOH) studies in sporadic breast cancers have pointed to several candidate loci for breast cancer g …
Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer.
Domchek SM, Jhaveri K, Patil S, Stopfer JE, Hudis C, Powers J, Stadler Z, Goldstein L, Kauff N, Khasraw M, Offit K, Nathanson KL, Robson M. Domchek SM, et al. Cancer. 2013 Apr 1;119(7):1344-8. doi: 10.1002/cncr.27842. Epub 2012 Nov 16. Cancer. 2013. PMID: 23165893 Free article.
BACKGROUND: This study sought to estimate the risk of breast cancer (BC) after a diagnosis of ovarian cancer (OC) associated with mutation of the BRCA1/2 (breast cancer, early onset) genes (BRCA-OC). METHODS: The Memorial Sloan-Kettering Cancer Center …
BACKGROUND: This study sought to estimate the risk of breast cancer (BC) after a diagnosis of ovarian cancer (OC) associated with mutation o …
The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Stacey SN, et al. PLoS Med. 2006 Jul;3(7):e217. doi: 10.1371/journal.pmed.0030217. PLoS Med. 2006. PMID: 16768547 Free PMC article.
The alleleic frequency was 0.037 in a high-predisposition group of cases defined by having a family history of breast cancer, early onset of breast cancer, or multiple primary breast cancers (OR = 2.41, 95% CI 1.22-4.75, p = 0.015). ...
The alleleic frequency was 0.037 in a high-predisposition group of cases defined by having a family history of breast cancer, …
DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals.
Sigurdson AJ, Hauptmann M, Alexander BH, Doody MM, Thomas CB, Struewing JP, Jones IM. Sigurdson AJ, et al. Mutat Res. 2005 Oct 3;586(2):173-88. doi: 10.1016/j.mrgentox.2005.07.001. Mutat Res. 2005. PMID: 16099702
To assess capacity to modulate endogenous DNA damage among radiologic technologists who had been diagnosed with breast cancer and another malignancy (breast-other, n=42), early-onset breast cancer (early-onset, age <or=35; n=38), thyroid cancer (n=6 …
To assess capacity to modulate endogenous DNA damage among radiologic technologists who had been diagnosed with breast cancer and another ma …
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer.
Faluyi OO, Gourley C, Smyth JF, Faratian D, Williams AR, Rye T, Rye R, Stewart M, Mackean MJ. Faluyi OO, et al. Int J Gynecol Cancer. 2010 Dec;20(9):1511-7. Int J Gynecol Cancer. 2010. PMID: 21370594
CONCLUSIONS: Ovarian cancer patients with a history of early breast cancer have a higher incidence of brain metastases and a different pattern of disease recurrence. We speculate that a higher incidence of breast cancer early onset mutations in patient …
CONCLUSIONS: Ovarian cancer patients with a history of early breast cancer have a higher incidence of brain metastases and a different patte …
BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls.
Bosviel R, Garcia S, Lavediaux G, Michard E, Dravers M, Kwiatkowski F, Bignon YJ, Bernard-Gallon DJ. Bosviel R, et al. Cancer Epidemiol. 2012 Jun;36(3):e177-82. doi: 10.1016/j.canep.2012.02.001. Epub 2012 Mar 7. Cancer Epidemiol. 2012. PMID: 22402307
We investigated the clinical and prognostic importance of whole blood breast cancer early onset gene 1 (BRCA1) DNA methylation in sporadic breast cancer. ...
We investigated the clinical and prognostic importance of whole blood breast cancer early onset gene 1 (BRCA1) D …
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.
Cremers RG, Eeles RA, Bancroft EK, Ringelberg-Borsboom J, Vasen HF, Van Asperen CJ; IMPACT Steering Committee; Schalken JA, Verhaegh GW, Kiemeney LA. Cremers RG, et al. Urol Oncol. 2015 May;33(5):202.e19-28. doi: 10.1016/j.urolonc.2015.01.018. Epub 2015 Mar 5. Urol Oncol. 2015. PMID: 25746941 Free article.
OBJECTIVE: To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prostate cancer (PC) screening among breast cancer, early-onset gene (BRCA) mutation carriers. This study was performe …
OBJECTIVE: To evaluate the additive value of the prostate cancer gene 3 (PCA3) urine test to serum prostate-specific antigen (PSA) in prosta …
Protein stability versus function: effects of destabilizing missense mutations on BRCA1 DNA repair activity.
Gaboriau DC, Rowling PJ, Morrison CG, Itzhaki LS. Gaboriau DC, et al. Biochem J. 2015 Mar 15;466(3):613-24. doi: 10.1042/BJ20141077. Biochem J. 2015. PMID: 25748678
Mutations in breast cancer susceptibility gene BRCA1 (breast cancer early-onset 1) are associated with increased risk of developing breast and ovarian cancers. ...
Mutations in breast cancer susceptibility gene BRCA1 (breast cancer early-onset 1) are associated with increased …
12 results